Compositions and their uses directed to hepcidin

Details Compositions and their uses directed to hepcidin Compositions and their uses directed to hepcidin

2007-04-12

2011-12-13

McGarry, Sean (Department: 1635)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

C435S006120, C435S375000, C536S023100, C536S024100, C536S024500

Reexamination Certificate

active

08076306

ABSTRACT:
Disclosed herein are compounds, compositions and methods for modulating the expression of hepcidin in a cell, tissue or animal or preventing, ameliorating or treating anemia. Also provided are methods for prevention, amelioration or treatment of anemia, and for increasing red blood cell count in an animal. Also provided are methods for the prevention, amelioration and/or treatment of low serum iron levels, low red blood cell count and other clinical endpoints of anemia in an animal. These methods may be achieved by administration of compounds or compositions including antisense compounds targeted to a nucleic acid that expresses hepcidin polypeptide combined with an erythropoiesis stimulating agent.

REFERENCES:
patent: 5801154 (1998-09-01), Baracchini et al.
patent: 5998148 (1999-12-01), Bennett et al.
patent: 6582908 (2003-06-01), Fodor et al.
patent: 7169758 (2007-01-01), Nicolas et al.
patent: 7411048 (2008-08-01), Kulaksiz et al.
patent: 2001/0053519 (2001-12-01), Fodor et al.
patent: 2003/0228597 (2003-12-01), Cowsert et al.
patent: 2004/0259247 (2004-12-01), Tuschl et al.
patent: 2007/0031844 (2007-02-01), Khvorova et al.
patent: 2007/0275913 (2007-11-01), Monia et al.
patent: WO 02/098444 (2002-12-01), None
patent: WO 2004/058044 (2004-07-01), None
Bennett et al. Biochimica et Biophysica Acta vol. 1489:19-30, 1999.
Vickers et al., The Journal of Biological Chemistry vol. 278(9):7108-7118, 2003.
Chin, Andrew “On the Preparation and Utilization of Isolated and Purified Oligonucleotides.” Document purportedly located on a CD-ROM and contributed to the public collection of the Katherine R. Everett Law Library of the University of North Carolina on Mar. 14, 2002.
Crosby, et al. “Targeting hepcidin with antisense olionucleotides improves anemia endpoints in mice.” Blood. vol. 108, No. 11, Part 1, Nov. 2006, pp. 83A-84A.
International Search Report from PCT/US2007/009269, dated Jan. 30, 2008.
New England BioLabs, Inc. Catalogue (1998): 121, 284.
Reynolds et al., Rational siRNA design for RNA interference, Mar. 2004, Nature Biotechnology, vol. 22, pp. 326-330.
Branch et al., “A good antisense molecule is hard to find,” TIBS (1998) 23:45-50.
Crooke et al., “Basic Principles of Antisense Therapeutics” Antisense Research and Application (1998) Chapter 1:1-50.
Merle et al. “The Iron Regulatory Peptide Hepcidin Is Expressed in the Heart and Regulated by Hypoxia and Inflammation”. Endocrinology 148(6):2663-2668. 2007.
Sanghvi et al., “Heterocyclic Base Modifications in Nucleic Acids and Their Applications in Antisense Oligonucleotides” Antisense Research and Applications (1993) pp. 273-288.
Ilyin et al. “Comparative analysis of mouse hepcidin 1 and 2 genes: evidence for different patterns of expression and co-inducibility during iron overload.” FEBS Letters 542 (2003) 22-26.
Gleeson et al. “Hepatic iron metabolism gene expression profiles in HFE associated Hereditary Hemochromatosis.” ScienceDirect. Blood Cells, Molecules, and Diseases 38 (2007) 37-44.
Babitt et al. “Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression.” Nature Genetics. vol. 38, No. 5, May 2006.
Sharma et al. “A role for tumour necrosis factor α in human small bowel iron transport.” Biochem. J. (2005) 390, 437-446.
Pak et al. “Suppression of hepcidin during anemia requires erythropoietic activity.” Blood, Dec. 1, 2006, vol. 108, No. 12.
Lin et al. “Competitive regulation of hepcidin mRNA by soluble and cell-associated hemojuvelin.” Blood, Oct. 15, 2005, vol. 106, No. 8.
Nicolas et al. “Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice.” PNAS, Jul. 17, 2001, vol. 98, No. 15.
Brett P. Monia, “Targeting Hepcidin with Antisense Oligonucleotides Improves Anemia Endpoints in Mice.” Presentation from Dr. Monia, an employee of Isis Pharmaceuticals, Inc. Dec. 2006.
Lee et al. “Regulation of hepcidin transcription by interleukin-1 and interleukin-6.” PNAS, Feb. 8, 2005, vol. 102, No. 6 1906-1910.
Lesbordes-Brion et al. “Targeted disruption of the hepcidin 1 gene results in severe hemochromatosis.” Blood, Aug. 15, 2006, vol. 108, No. 4.
Lee et al. “The IL-6 and lipopolysaccharide-induced transcription of hepcidin in HFE-, transferring receptor 2-, and β2-microglobulin-deficient hepatocytes.” PNAS, Jun. 22, 2004, vol. 101, No. 25, 9263-9265.
Laftah et al. “Effect of hepcidin on intestinal iron absorption in mice.” Blood, May 15, 2004, vol. 103, No. 10.
Pigeon et al. “A New Mouse Liver-specific Gene, Encoding a Protein Homologous to Human Antimicrobial Peptide Hepcidin, Is Overexpressed during Iron Overload.” The Journal of Biological Chemistry (2001) vol. 276, No. 11, 7811-7819.
Nicolas et al. “The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation.” The Journal of Clinical Investigation, Oct. 2002, vol. 110, No. 7.
Park et al. “Hepcidin, a Urinary Antimicrobial Peptide Synthesized in the Liver.” The Journal of Biological Chemistry (2001) vol. 276, No. 11, 7806-7810.
European Search Report for European Patent Application No. EP 10177775 filed Apr. 12, 2007.
International Search Report and Written Opinion for International Application No. PCT/US2007/009269 filed Apr. 12, 2007.
International Preliminary Report on Patentability for International Application No. PCT/US2007/009269 filed Apr. 12, 2007.

Affiliated with

Also associated with

Rating

Compositions and their uses directed to hepcidin does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compositions and their uses directed to hepcidin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and their uses directed to hepcidin will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4306149